The rationale for a lower F&A rate for clinical studies is that those
indirect costs associated with wet lab space and other items are not
applicable to clinical research. Therefore, for all research, regardless of
sponsor, we request our negotiated rate. Of course, there are sponsors that
limit F&A cost recovery. For those instances, I have a "Waiver of F&A costs"
on the internal Administrative Approval form so that the "Institution" can
approve a lower than negotiated F&A rate...Bill

Bill Caskey, PhD
Director, Research & Grants Administration
Children's Mercy Hospital
2401 Gillham Road
Kansas City, MO  64108

Voice:(816) 234-3879
FAX:(816) 855-1982
E-mail:  xxxxxx@cmh.edu <mailto:xxxxxx@cmh.edu>

This communication is intended only for the use of the addressee.  It may
contain information which is privileged or confidential under applicable
law.  If you are not the intended recipient or the agent of the recipient,
you are hereby notified that any dissemination, copy or disclosure of this
communication is strictly prohibited. If you have received this
communication in error, please immediately notify The Children's Mercy
Hospital at 816-234-3879 or via return Internet electronic mail at
xxxxxx@cmh.edu <mailto:xxxxxx@cmh.edu>  and expunge this communication
without making any copies.  Thank you for your cooperation.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================